Defining the optimal treatment strategy for localized prostate cancer patients: a survey of ongoing studies at the National Cancer Institute of Canada Clinical Trials Group

The designation “clinically localized prostate cancer” comprises a group of biologically heterogeneous tumours with different growth rates and risks of relapse. Because prostate cancer is primarily a disease of older men, treatment selection must take into account the prognosis of the tumour, patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Parulekar, W.R., McKenzie, M., Chi, K.N., Klotz, L., Catton, C., Brundage, M., Ding, K., Hiltz, A., Meyer, R., Saad, F.
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2008
Materias:
Canadian Centre Activities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528309/
https://www.ncbi.nlm.nih.gov/pubmed/18769611

Ejemplares similares

Ejemplares similares